Glyxambi 10/5 substitute?

Glyxambi 10 mg / 5 mg is a fixed‑dose combination of

Because Glyxambi is the only commercially available fixed‑dose combo of empagliflozin + linagliptin, a direct substitute (i.e., a different brand with the same 10 / 5 ratio) does not exist.
If you’re looking for another therapy that offers the same two‑mechanism approach, you have a few options:

1. Take the two drugs separately

Why this works: You’re essentially recreating Glyxambi at the same dose, but the patient will be swallowing two pills instead of one.

2. Use a different SGLT‑2 + DPP‑4 combo (off‑label)

Note: Using separate pills is the same idea—just a different SGLT‑2 and DPP‑4 pair. The pharmacodynamics will differ slightly, so titration or monitoring may be required.

3. Switch to a single‑class regimen that provides similar benefits

When to consider this: If the dual‑mechanism approach is not essential, a single‑class agent (especially a GLP‑1 agonist or metformin) might achieve the desired glycaemic goal with fewer pills.

4. Consider non‑pharmacologic adjustments

Practical Tips for Switching

1. Timing – If you’re switching from Glyxambi to separate pills, you can start both empagliflozin + linagliptin the same day. There’s no need to stagger doses; they’re taken once daily and can be taken together.
2. Monitoring – Watch for signs of volume depletion (dizziness, orthostatic hypotension), genital or urinary tract infections, and, rarely, euglycaemic ketoacidosis (especially with SGLT‑2 inhibitors). Check fasting glucose and HbA1c every 4–12 weeks after any change.
3. Renal function – Empagliflozin dose remains 10 mg regardless of eGFR down to 30 mL/min/1.73 m²; linagliptin requires no dose adjustment even at eGFR < 30.
4. Drug interactions – Be mindful of antidiuretic agents (e.g., demeclocycline), diuretics, ACE inhibitors, ARBs, and NSAIDs, which can affect blood pressure and renal function.
5. Insurance & cost – Check if the separate agents are covered separately or if a different fixed‑dose combo offers a cost advantage.

Bottom Line

• There is no other brand‑name drug that exactly replicates Glyxambi 10/5.
• You can achieve the same therapeutic effect by taking empagliflozin 10 mg + linagliptin 5 mg as two separate tablets, or by pairing a different SGLT‑2 inhibitor with a DPP‑4 inhibitor off‑label.
• Alternatively, consider a single‑class therapy (e.g., GLP‑1 agonist, metformin, or SGLT‑2 inhibitor alone) if the dual mechanism is not strictly necessary.
• Always consult your prescribing clinician before making any medication changes to ensure safety and optimal glycaemic control.

Let me know if you’d like specific dosing tables, side‑effect profiles, or help with insurance formulary questions!